Final results of sequential phase 2 studies of palbociclib (PD0332991) in CDK4-amplified liposarcoma Meeting Abstract


Authors: Dickson, M.; Tap, W. D.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; Singer, S.; Schwartz, G. K.
Abstract Title: Final results of sequential phase 2 studies of palbociclib (PD0332991) in CDK4-amplified liposarcoma
Meeting Title: 17th European Cancer Conference (ECCO 17)
Journal Title: European Journal of Cancer
Volume: 49
Issue: Suppl. 2
Meeting Dates: 2013 Sep 27-Oct 1
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2013-09-01
Start Page: S884
Language: English
ACCESSION: WOS:000326843605395
PROVIDER: wos
DOI: 10.1016/S0959-8049(13)70065-0
Notes: Meeting Abstract: 3826 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Cristina R Antonescu
    895 Antonescu
  3. Jonathan Landa
    37 Landa
  4. Li-Xuan Qin
    190 Qin
  5. Aimee Marie Crago
    106 Crago
  6. Samuel Singer
    337 Singer
  7. Mark Andrew Dickson
    169 Dickson
  8. William Douglas Tap
    372 Tap